n6 Expanded Global Distribution for Biotech Instruments
The firm added new distribution channels for its iconPCR and AutoNorm workflows across European and international markets.
Updated on Oct. 10, 2026 in Biotech
Live Poll
Do you trust that new automated lab technologies simplify complex research workflows?
n6 has officially expanded its global distribution network to increase access to its automated genomics preparation workflows. This growth includes new partnerships aimed at delivering iconPCR and AutoNorm instruments to additional regions.
Why it matters
The expansion reflects a strategic effort to improve global access to scalable next-generation sequencing library preparation. By leveraging local expertise, the company intends to streamline complex molecular workflows for researchers worldwide.
The iconPCR platform enables amplification, quantification, and normalization in a single step, while AutoNorm technology manages control at the individual-sample level. These workflows are currently active in more than 25 countries.
The players
n6
A biotechnology company specializing in automated molecular workflow instrumentation and next-generation sequencing preparation.
Morpho Biotech
A distribution firm now responsible for handling market access for n6 instruments in Germany, Belgium, Luxembourg, and the Netherlands.
Bioseen Trading LLC
A trading entity serving as the representative for n6 distribution and technical support across the Gulf Region.
Inqaba Biotec
A channel partner firm that facilitates the delivery and support of biotechnology instruments across various African markets.
The details
Morpho Biotech now manages distribution in Germany, Belgium, Luxembourg, and the Netherlands, while Bioseen Trading LLC covers the Gulf Region. Additionally, Inqaba Biotec acts as the channel partner for various African markets to provide technical and market support.
Timeline
October 10, 2026: Official announcement of distribution partnership expansion.
Second half of 2026: Planned participation in various scientific meetings and workshops.
The Tech Race
The expansion follows a trend of integrating new instrumentation into major international research forums like the EMBL Transcription and Chromatin conference. This move positions n6 to compete by securing widespread adoption of its automated workflow systems ahead of key 2026 scientific meetings.
Researchers and laboratories in newly served regions will gain improved access to technical support and standardized NGS library preparation workflows. This allows local labs to implement automated, single-step amplification and normalization protocols more efficiently.
The takeaway
The growth of n6 infrastructure highlights the ongoing push toward high-throughput, automated molecular diagnostics. Researchers should look for upcoming local workshops as opportunities to evaluate how these new distribution channels can simplify their laboratory workflows.
What happens next
n6 and its partners will participate in scientific meetings throughout the second half of 2026, including planned workshops at the EMBL Transcription and Chromatin conference in Italy, Singapore, and Japan.
Further reading
For broader context on developments in the field, visit the /tech/biotech/ section.
Source note: This article includes information reported by News-Medical.
Live Poll
Do you trust that new automated lab technologies simplify complex research workflows?
